Skip to main content
Orexo logo

Orexo — Investor Relations & Filings

Ticker · ORX ISIN · SE0000736415 LEI · 549300LJ5CCWDPTK9Z08 ST Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2014-04-30 Capital/Financing Update
Country SE Sweden
Listing ST ORX

About Orexo

https://orexo.com/

Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.

Recent filings

Filing Released Lang Actions
Orexo issues a SEK 500 million bond loan on the Swedish bond market
Capital/Financing Update Classification · 1% confidence The document is a press release announcing that Orexo AB has decided to issue a SEK 500 million senior unsecured bond loan. Key terms mentioned include the maturity date (May 9, 2018), the interest rate (Stibor 3m + 4.00%), and the intent to list the bonds on NASDAQ OMX Stockholm. This activity directly relates to the company's fundraising, financing activities, and capital structure. Therefore, it fits the definition of 'Capital/Financing Update' (CAP). The document length is short (2427 chars), but it is the primary announcement of the financing event itself, not an announcement *about* a report, making CAP more specific than RPA or RNS.
2014-04-30 English
Orexo emitterar obligationslån om 500 MSEK på den svenska obligationsmarknaden
Capital/Financing Update Classification · 1% confidence The document is titled 'Pressmeddelande' (Press Release) and explicitly announces that 'Orexo emitterar obligationslån om 500 MSEK' (Orexo issues a bond loan of 500 MSEK). This action involves fundraising, financing activities, and changes to the capital structure (issuing debt). This directly matches the definition for Capital/Financing Update (CAP). It is not an earnings release (ER) as it discusses debt issuance, nor is it a general regulatory filing (RNS) because it fits a more specific category.
2014-04-30 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 1% confidence The document is a quarterly financial report ('Delårsrapport') for Orexo AB for the first quarter of 2014. It contains detailed financial statements, including income statements, cash flow data, and management commentary on business performance, product launches (Zubsolv, Abstral), and development programs. It is not an announcement of a report, but the report itself, containing substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2014
2014-04-25 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim report January-March 2014' and contains detailed financial statements, management commentary, and operational updates for the first quarter of 2014. It provides comparative data for the same period in 2013 and includes a table of financial highlights. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2014
2014-04-25 English
Kommuniké från Orexo AB:s årsstämma den 15 april 2014
AGM Information Classification · 1% confidence The document is explicitly titled 'Kommuniké från Orexo AB:s årsstämma den 15 april 2014' (Communiqué from Orexo AB's Annual General Meeting on April 15, 2014). It details decisions made regarding the election of the board, remuneration, approval of financial statements for 2013, and authorizations for share issuance and buybacks, all typical outcomes of an AGM. This directly corresponds to the AGM Information category.
2014-04-15 Swedish
Report from Orexo AB’s annual general meeting, 15 April 2014
AGM Information Classification · 1% confidence The document is explicitly titled "Report from Orexo AB's annual general meeting, 15 April 2014". It details resolutions passed regarding the election of the board, auditor fees, approval of financial statements, dividend decisions, and authorizations for share issuance/repurchase, which are all standard items discussed and voted upon at an Annual General Meeting (AGM). This directly corresponds to the AGM Information category.
2014-04-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.